The FDA Has Approved Niraparib (Zejula) for Platinum-Sensitive Recurrent Ovarian Cancer
source: pixabay.com

The FDA Has Approved Niraparib (Zejula) for Platinum-Sensitive Recurrent Ovarian Cancer

Dr. Oliver Dorigo of the Stanford University Medical Center was the medical source for an article featured in Oncology. Dr. Dorigo explained that if a woman with ovarian cancer has…

Continue Reading The FDA Has Approved Niraparib (Zejula) for Platinum-Sensitive Recurrent Ovarian Cancer
Data for an Experimental Pompe Disease Therapy to be Presented at Upcoming Conference
source: pixabay.com

Data for an Experimental Pompe Disease Therapy to be Presented at Upcoming Conference

According to a press release from Sanofi, platform and poster presentations focused on the company's investigational product candidate avalglucosidase alfa are slated to be made public at the 17th annual…

Continue Reading Data for an Experimental Pompe Disease Therapy to be Presented at Upcoming Conference
Researchers Illuminate Link Between Type 2 Diabetes, Chronic Kidney Disease, and Left Ventricular Strain
source: pixabay.com

Researchers Illuminate Link Between Type 2 Diabetes, Chronic Kidney Disease, and Left Ventricular Strain

A study has recently highlighted the fact that patients who have type 2 diabetes are more susceptible to chronic kidney disease (CKD), and as a result, cardiac issues. This study…

Continue Reading Researchers Illuminate Link Between Type 2 Diabetes, Chronic Kidney Disease, and Left Ventricular Strain

The First Duchenne Muscular Dystrophy Patient Receives Gene Therapy Treatment in Pfizer’s Phase 3 Trial

The very first patient has just been dosed in Pfizer's Phase 3 clinical trial for Duchenne muscular dystrophy (DMD). The trial is called CIFFREO. This patient received the therapy at a…

Continue Reading The First Duchenne Muscular Dystrophy Patient Receives Gene Therapy Treatment in Pfizer’s Phase 3 Trial
NDA for Potential Progressive Familial Intrahepatic Cholestasis Treatment Cleared by FDA
source: pixabay.com

NDA for Potential Progressive Familial Intrahepatic Cholestasis Treatment Cleared by FDA

According to a press release from the rare liver disease company Albireo Pharma, Inc., the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for odevixibat.…

Continue Reading NDA for Potential Progressive Familial Intrahepatic Cholestasis Treatment Cleared by FDA
FDA Gives Priority Review for What Could be the First Therapy for Eosinophilic Esophagitis
source: pixabay.com

FDA Gives Priority Review for What Could be the First Therapy for Eosinophilic Esophagitis

Takeda has just announced that their application to the the FDA for their eosinophilic esophagitis (EoE)  investigative therapy has received Priority Review. This therapy is called budesonide oral suspension or…

Continue Reading FDA Gives Priority Review for What Could be the First Therapy for Eosinophilic Esophagitis
A Shared Rare Condition and a Shared Dream: How Ehlers-Danlos Syndrome Connected Miss America and Ms. Wheelchair Virginia
source: pixabay.com

A Shared Rare Condition and a Shared Dream: How Ehlers-Danlos Syndrome Connected Miss America and Ms. Wheelchair Virginia

Ryan Kress was crowned Ms. Wheelchair Virginia 2020 and Camille Schrier was crowned Miss America 2020. Besides their titles, what brings these two individuals together is their medical diagnosis with…

Continue Reading A Shared Rare Condition and a Shared Dream: How Ehlers-Danlos Syndrome Connected Miss America and Ms. Wheelchair Virginia
Inventiva Introduces Design for its Phase III Nonalcoholic Steatohepatitis Trial
source: pixabay.com

Inventiva Introduces Design for its Phase III Nonalcoholic Steatohepatitis Trial

According to a story from dernieresactus.fr, the biopharmaceutical company Inventiva has recently announced plans for its upcoming phase III clinical trial. This trial will investigate its lead candidate lanifibranor as…

Continue Reading Inventiva Introduces Design for its Phase III Nonalcoholic Steatohepatitis Trial